These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16490268)

  • 1. The ribosome as a drug target.
    Böttger EC
    Trends Biotechnol; 2006 Apr; 24(4):145-7. PubMed ID: 16490268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based drug design meets the ribosome.
    Franceschi F; Duffy EM
    Biochem Pharmacol; 2006 Mar; 71(7):1016-25. PubMed ID: 16443192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unnatural rigid scaffolds targeting the bacterial ribosome.
    Katsoulis IA; Pyrkotis C; Papakyriakou A; Kythreoti G; Zografos AL; Mavridis I; Nahmias VR; Anastasopoulou P; Vourloumis D
    Chembiochem; 2009 Aug; 10(12):1969-72. PubMed ID: 19585638
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs targeting the ribosome.
    Hermann T
    Curr Opin Struct Biol; 2005 Jun; 15(3):355-66. PubMed ID: 15919197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA structure: reading the ribosome.
    Noller HF
    Science; 2005 Sep; 309(5740):1508-14. PubMed ID: 16141058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a 70S ribosome-tRNA complex reveals functional interactions and rearrangements.
    Korostelev A; Trakhanov S; Laurberg M; Noller HF
    Cell; 2006 Sep; 126(6):1065-77. PubMed ID: 16962654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo selection of functional variations in essential sites of ribosomal RNA.
    Moine H; Ehresmann B; Ehresmann C
    Methods; 2001 Nov; 25(3):358-64. PubMed ID: 11860290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-specific antibiotic-ribosome interactions: implications for drug development.
    Wilson DN; Harms JM; Nierhaus KH; Schlünzen F; Fucini P
    Biol Chem; 2005 Dec; 386(12):1239-52. PubMed ID: 16336118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of nucleotides in E. coli 16S rRNA essential for ribosome subunit association.
    Pulk A; Maiväli U; Remme J
    RNA; 2006 May; 12(5):790-6. PubMed ID: 16556933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic deletion of rRNAs for investigating ribosome architecture and function.
    Kitahara K; Sato NS; Namba N; Yokota T; Tsujimura T; Suzuki T
    Nucleic Acids Symp Ser (Oxf); 2006; (50):287-8. PubMed ID: 17150930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel GTPase activated by the small subunit of ribosome.
    Himeno H; Hanawa-Suetsugu K; Kimura T; Takagi K; Sugiyama W; Shirata S; Mikami T; Odagiri F; Osanai Y; Watanabe D; Goto S; Kalachnyuk L; Ushida C; Muto A
    Nucleic Acids Res; 2004; 32(17):5303-9. PubMed ID: 15466596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling.
    Borovinskaya MA; Pai RD; Zhang W; Schuwirth BS; Holton JM; Hirokawa G; Kaji H; Kaji A; Cate JH
    Nat Struct Mol Biol; 2007 Aug; 14(8):727-32. PubMed ID: 17660832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Following the dynamics of changes in solvent accessibility of 16 S and 23 S rRNA during ribosomal subunit association using synchrotron-generated hydroxyl radicals.
    Nguyenle T; Laurberg M; Brenowitz M; Noller HF
    J Mol Biol; 2006 Jun; 359(5):1235-48. PubMed ID: 16725154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-resolved binding of azithromycin to Escherichia coli ribosomes.
    Petropoulos AD; Kouvela EC; Starosta AL; Wilson DN; Dinos GP; Kalpaxis DL
    J Mol Biol; 2009 Jan; 385(4):1179-92. PubMed ID: 19071138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural studies of E. coli ribosomes by spectroscopic techniques: a specialized review.
    Bonicontro A; Risuleo G
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Dec; 62(4-5):1070-80. PubMed ID: 15950526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for messenger RNA movement on the ribosome.
    Yusupova G; Jenner L; Rees B; Moras D; Yusupov M
    Nature; 2006 Nov; 444(7117):391-4. PubMed ID: 17051149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of the determinants of the cyclic, sequential binding of elongation factors tu and g to the ribosome.
    Yu H; Chan YL; Wool IG
    J Mol Biol; 2009 Feb; 386(3):802-13. PubMed ID: 19154738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of BODIPY-erythromycin probes for bacterial ribosomes.
    Li J; Kim IH; Roche ED; Beeman D; Lynch AS; Ding CZ; Ma Z
    Bioorg Med Chem Lett; 2006 Feb; 16(4):794-7. PubMed ID: 16309904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using sequence-specific oligonucleotides to inhibit bacterial rRNA.
    Trylska J; Thoduka SG; Dąbrowska Z
    ACS Chem Biol; 2013; 8(6):1101-9. PubMed ID: 23631412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of the residues C770 and G771 of E. coli 16S rRNA implicated in forming the intersubunit bridge B2c of the ribosome.
    Kim HM; Yeom JH; Ha HJ; Kim JM; Lee K
    J Microbiol Biotechnol; 2007 Jul; 17(7):1204-7. PubMed ID: 18051334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.